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Background. Loss of function of dimeric glucose-6-phosphate dehydrogenase (G6PD) represents the most common inborn
error of metabolism throughout the world affecting an estimated 400 million people. In Germany, this enzymopathy is very
rare. Methodology/Principal Findings. On the basis of G6PD crystal structures, we have analyzed six G6PD variants of
German ancestry by three-dimensional modeling. All mutations present in the German population are either close to one of
the three G6P or NADP
+ units or to the interface of the two monomers. Two of the three mutated amino acids of G6PD
Vancouver are closer to the binding site of NADP
+. The G6PD Aachen mutation is also closer to the second NADP
+ unit. The
G6PD Wayne mutation is closer to the G6P binding region. These mutations may affect the binding of G6P and NADP
+ units.
Three mutations, i.e. G6PD Munich, G6PD Riverside and G6PD Gastonia, lie closer to the interface of the two monomers. These
may also affect the interface of two monomers. Conclusion. None of these G6PD variants share mutations with the common
G6PD variants known from the Mediterranean, Near East, or Africa indicating that they have developed independently. The
G6PD variants have been compared with mutants from other populations and the implications for survival of G6PD variants
from natural selection have been discussed.
Citation: Kiani F, Schwarzl S, Fischer S, Efferth T (2007) Three-Dimensional Modeling of Glucose-6-phosphate Dehydrogenase-Deficient Variants from
German Ancestry. PLoS ONE 2(7): e625. doi:10.1371/journal.pone.0000625
INTRODUCTION
Loss of function of dimeric glucose-6-phosphate dehydrogenase
(G6PD) represents the most common inborn error of metabolism
throughout the world affecting an estimated 400 million people
[1]. Prolonged neonatal jaundice and hemolytic anemia are
common clinical manifestations. Infections, ingestion of fava
beans, and some drugs can trigger life-threatening hemolytic
anemia. G6PD is the first enzyme of the pentose phosphate
pathway that converts b-D-glucose-6-phosphate into D-glucono-
1,5-lactone-6-phosphate and is involved in the generation of
NADPH [2]. As erythrocytes lack the citric acid cycle, the pentose
phosphate shunt is the only source of NADPH. NADPH is
required for the generation of reduced glutathione, which is
important for the protection against oxidative damage.
As the G6PD gene is located at the X-chromosome at Xq28 [3]
the disease is recessively inherited in males. In the past, more than
400 variants have been proposed based on clinical and enzymatic
properties [4]. Precise molecular characterization of the G6PD
gene showed that these 400 variants correspond to only 140
mutations. These are mainly 140 missense mutations leading to
amino-acid substitutions and in a few cases base pair deletions that
do not produce frame shifts are known [5]. Few splicing mutations
have been documented [6,7]. American, Mediterranean, and
African ancestries are the best analyzed forms as of yet. In contrast
to Southern European countries, only few variants are known
from Middle and Northern Europe [8,9].
In extension to previous investigations on the three-dimensional
structure of G6PD and structural localization of variants [10,11],
we now report the modeling of G6PD variants of German origin.
RESULTS
On the basis of relocation of all entries of two monomers of 2BH9
over those of 1QKI, the resulting structure is shown in Figure 1A.
Each G6PD monomer has two NADP
+ units and one G6P unit.
All six mutations coming from German ancestry are highlighted in
Van der Waals presentations in red circles in Figure 1B. Except for
the Vancouver mutation, which is a triple mutant, all other
mutations in German populations are single point mutations
(Figure 1C). All mutations present in the German population are
either close to one of the three G6P or NADP
+ units or to the
interface of the two monomers. Two of the three mutated amino
acids, i.e. Arg198Cys and Trp182Trp are close to the binding site
of NADP
+. The Aachen mutation is close to the second NADP
+
unit. The Wayne Arg198Gly mutation is close to the G6P binding
region. Thus, these mutations may affect the binding of G6P and
NADP
+ units. Three mutations, i.e. Munich, Riverside and
Gastonia, lie close to the interface of the two monomers. Thus
these may affect the interaction between the two monomers. None
of the mutations introduced a major structural change upon
energy minimization. All mutations are within an RMSD value of
1.2 A ˚ (Figure 1D), indicating that the mutations can be
accommodated by simple flexible deformation of the protein.
Next, we compared the clinical appearance of these and other
G6PD variants from Germany with those from other populations.
In addition to the G6PD variants from German ancestry described
in Figure 1, a number of other variants have been described in the
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level. The classification according to the clinical symptoms showed
that most of these variants belong to the classes 1 or two (Table 1).
Only one variant was a borderline class 2 or 3 G6PD deficiency
(G6PD Frankfurt).
DISCUSSION
G6PD deficiency is very frequent in Africa, Middle East, and
Southeast Asia, but rare in Northern Europe (including Germany)
or Northern America (except African Americans). This raises the
question, whether differences in population genetics might account
for this phenomenon. Rather than genetic or biological borders
among human populations and tribes, the geographical distribu-
tion contributes to the cumulative occurrence of different forms of
G6PD deficiency. The Mediterranean variants are not or rarely
found in Asia or America. The fact that Japan is an island may
explain the restricted occurrence of the G6PD Japan variant to
this geographical area [12].
In the present investigation, we describe the three-dimensional
localization of the structural modification in six G6PD class 1
variants of German origin. It is intriguing that none of the
common Mediterranean variants are found in Germany as of yet.
As can be seen in Table 2 and 3, some G6PD variants are
restricted to certain areas and regions, while others are more
widely spread. G6PD variants with locally restricted occurrence
speak for an independent development during evolution. On the
other side, a number of G6PD variants were found in
Mediterranean and Middle-Eastern European populations as well
as in the Near and Middle East suggesting a significant gene flow
from Near East both to South-Eastern Europe and via sub-
Saharan Africa to the South Mediterranean [13,14]. An enhanced
distribution of G6PD deficiency may have taken place by Greek
settlers, who established many colonies throughout the Mediter-
ranean world in ancient times [15]. In spite of this distribution of
G6PD deficiency over Europe the question arises, why the
common Mediterranean mutations were not found in German
populations suffering from G6PD deficiency.
Different hypotheses can be entertained to explain the differing
occurrence of G6PD deficiency in various areas and populations.
One point of view is that G6PD deficiency has independently
developed with comparable frequencies in different areas. This is
true for G6PD class 1 variants, which are found as sporadic cases
worldwide and which cause chronic hemolytic anemia. Class 2 or
class 3 G6PD deficiency is different from class 1. These forms are
better tolerated except in case of oxidative stress leading to
a hemolytic crisis. Class 2 and 3 variants have been selected by
malaria. Diminished concentrations of reduced glutathione may
represent a permissive environment for protozoal parasites such as
Plasmodium falciparum. Hence, G6PD mutations are protective
against malaria [16]. A comparable convergent evolution between
protecting G6PD mutations and thalassemia or sickle cell anemia
has been proposed [17,18]. Malaria, thalassemia, and sickle cell
anemia may, therefore, exert a positive selection pressure for
Figure 1. Molecular modeling of G6PD variants of German ancestry. (A) Wild-type structure of G6PD, with NADP
+ entries from 2BH9 and G6P
entries from 2BHL (shown as van der Waals representation). The two chains are shown in green and blue. (B) The locations of the six mutations is
shown as green Van der Waal radii, highlighted by red circles. Beta sheets are shown in yellow color, while alpha helices are shown in blue color. (C
and D) The root mean square is taken over one monomer, comparing the optimized structure of the mutant and that of the wild type. Figures were
created with VMD software [28].
doi:10.1371/journal.pone.0000625.g001
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Germany, but was present in certain Mediterranean (i.e. Sardinia),
African and Arabian regions in former times, it is reasonable to
speculate that for this reason G6PD deficiency class 3 is not as
frequent as in areas plagued with malaria. Indeed, G6PD variants
class 3 from Germany are rarely described. Except of G6PD
Frankfurt, no other form appeared in the medical literature during
the past six decades (Table 3). This is in contrast to the occurrence
of G6PD variants on other populations, where class 3 mutants
appear with a much higher frequency [19]
It could also be argued that the Limes Germanicus (Latin for
German frontier) of the ancient Roman Empire, which separated
the roman empire from un-subdued German tribes and had its
maximum extent in the second century A.D., had a barrier
function further restricting the distribution of G6PD deficiency in
Middle European areas (if not distributed before the Roman
Empire and the Limes were established). Class 1 variants are
sporadic by definition, and apparently do not provide any
advantage against malaria. Falciparum malaria, the selective force
responsible for the expansion of class 2 G6PD variants (typically,
G6PD Mediterranean), was never present in Northern Europe.
The prevalence of falciparum (malignant) malaria was low during
the Roman Empire period. After the fall of the Empire, falciparum
malaria exploded and became endemic in some Southern region
due to the collapse of the irrigation system and expansion of
marshes. The Roman citizens (cives romani) were a minority in the
Northern provinces and largely outnumbered by the Romanized
local populations. Finally, the Limes was not an efficient barrier
against the inflowing large Germanic populations (barbari) that
came in during the following centuries. Very extensive admixture
of different German populations occurred later on, i.e., during the
Thirty Years’ War (1618–1648) and recently after the huge
population shifts in Germany after World War II. Hence, the
hypothesis of a barrier function of the Roman limes is not
convincing.
The fact that G6PD-deficiency is rare in Germany but relatively
common in the Mediterranean region and Northern Africa gave
rise to speculations in the past that G6PD-deficiency was spread
into German populations, as the Roman Empire had occupied the
countries beyond the Alps. Offspring of Roman soldiers of
Mediterranean or Northern African origin and German inhabi-
tants might have carried G6PD mutations leading to G6PD-
deficiency in German populations nowadays. This opinion, which
might have its roots in fascistic mindsets, seemed reasonable at
superficial consideration in ages when solely clinical or bio-
chemical data of G6PD deficiency were available. As of now, all
G6PD mutations of German ancestries are different at the DNA
level from the known Mediterranean and Northern African forms
of G6PD-deficiency. This clearly disproves the ambiguous idea
that G6PD deficiency appeared in Germany by mating of Roman
soldiers and German women.
In areas where malaria does not represent a challenge for
human populations, other weak influences may affect the
Table 2. Ubiquitous G6PD variants in Europe, Near East, and Africa
..................................................................................................................................................
G6PD variant Mutation Countries and regions
G6PD A- 202 G R A plus 376 A R G Near East, Poland, Italy, Spain, Nigeria, Mauritius,
G6PD Aures 143 TRC Near East, Spain, Algeria
G6PD Cassano 1347 GRC Greece, Croatia, Italy
G6PD Chatham 1003 GRA Near East, Italy, Spain
G6PD Cosenza 1376 G R C Croatia, Italy
G6PD Malaga 542 ART Poland, Spain
G6PD Mediterranean 563 C R T plus 1311 C R T Near East, Greece, Croatia, Bulgaria, Italy, Spain, Mauritius
G6PD Santamaria 542 ART plus 376 ARG Italy, Spain, Algeria
G6PD Seattle 844 GRC Greece, Croatia, Bulgaria, Italy, Spain, Algeria,
G6PD Tokyo 1246 G RA Poland, Italy
G6PD Union 1360 G R A Croatia, Italy, Spain
References: See supplementary file (Table S1)
doi:10.1371/journal.pone.0000625.t002
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Table 1. Classification of G6PD variants from German ancestry
......................................................................
G6PD variant Class Reference
G6PD Aachen 1 [20]
G6PD Berlin 1 [29]
G6PD Bielefeld 2 [30]
G6PD Bodensee (Schwaben) 2 [31]
G6PD Cologne 1 2 [32]
G6PD Cologne 2 1 [32]
G6PD Cologne 3 2 [32]
G6PD Frankfurt 2 or 3 [33]
G6PD Freiburg 1 [34], [35]
G6PD Gastonia 1 [36]
G6PD Hamburg 1 [37]
G6PD Hamm 1 [38]
G6PD Iserlohn 2 [39]
G6PD Magdeburg 2 [40]
G6PD Moosburg 1 [41]
G6PD Munich 1 E. Beutler, personal
communication
G6PD Regensburg 1 [39]
G6PD Riverside 1 [42]
G6PD Tu ¨bingen 1 [43], [44]
G6PD Vancouver 1 [45]
G6PD Wayne 1 [46]
G6PD Za ¨hringen 2 [47]
doi:10.1371/journal.pone.0000625.t001
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PLoS ONE | www.plosone.org 3 July 2007 | Issue 7 | e625manifestation of G6PD deficiency. A negative selection pressure
has been discussed for non-lethal disorders or rare inherited
syndromes. Decreased amounts of reduced glutathione may favour
disorders such as manic depression, red/green colour vision,
multiple sclerosis, diabetes mellitus, cataract, fragile X-syndrome
and others. A relationship between lethal diseases such as cancer
and G6PD deficiency has also been proposed. However, all these
associations are weak. If any, these factors may have a weak
influence on the manifestation of G6PD deficiency and may lead
to a reduction of the frequency of G6PD deficiency in German
populations. The most likely possibility is that the sporadic variants
that are observed in Germany really represent the effect of random
mutations. The mutations that are seen, then, represent the
balance between the rate at which these mutations occur and the
rate at which they are lost from the population. Except for the class
1 variants, which are probably lost very rapidly, most G6PD
deficiency has very little effect on fitness and is therefore relatively
slowly lost from the population.
MATERIALS AND METHODS
The German variants G6PD Aachen [20,21] and Munich [7] and
their mutations in the G6PD gene have been reported. G6PD
Wayne [22], G6PD Vancouver [23], G6PD Gastonia, and G6PD
Riverside (E. Beutler, unpublished data) are variants of patients of
German emigrants.
Three crystal structures available at the Protein Data Bank
(PDB, http://www.rcsb.org/pdb/) from human G6PD with PDB
codes 1QKI [10], 2BH9 and 2BHL [11] are similar in their
backbone folding. 1QKI (resolution=3.00 A ˚) is an octamer
consisting of four dimers, each with a point mutation at 459 Arg-
.Lys. 2BH9 (resolution=2.50 A ˚) has been crystallized as
a monomer with two NADP
+ units [11], while 2BHL (resolu-
tion=2.90 A ˚) has been crystallized as a dimer with two G6P units.
Both structures are without any mutation, but 2BHL has 25 N-
terminal residues missing. Since the smallest human glucose-6-
phosphate dehydrogenase functional unit is a dimer [24,25], we
started with a dimeric structure (Figure 1A). The structure was
obtained by positioning two 2BH9 monomers (along with their
NADP
+ units) as in the dimer of 1QKI. The G6P molecules were
taken from 2BHL after it was overlapped onto 2BH9 monomers.
Crystal water molecules were deleted. The mutant structures were
generated in a four-step procedure. a) Side chain replacement
according to mutant, b) energy minimization while keeping all
atoms except the side chain fixed, c) energy minimization by
allowing the side chain and all atoms around 8 A ˚ of the side chain
to move, and d) energy minimization while allowing all atoms to
move. Energy minimization was done at each step to a final root-
mean square gradient of 0.1 kcal/mol/A ˚ using the MAB force
field [26]. All mutants listed in Figure 1B were modelled and the
resulting structures were overlapped over the Wild Type. All
modelling was done using the Moloc program [27].
SUPPORTING INFORMATION
Table S1 Ubiquitous G6PD variants in Europe, Near East, and
Africa
Found at: doi:10.1371/journal.pone.0000625.s001 (0.06 MB
DOC)
Table S2 Endemic G6PD variants in Europe, Near East, and
Africa
Found at: doi:10.1371/journal.pone.0000625.s002 (0.05 MB
DOC)
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